Limitations Of Prostaglandin Assays  by Lands, William E M et al.
TtlE J OUH,;-'AL OF l:.;:n:STI(; i\T IH, DERMATOl.()(;' , 67 :6.~-660 , 1976 
Cop."rig ht © 1976 b." The \\"illiams & \\'ilk in~ Co, 
\ '() l. 6i. !\o, .~ , Part 2 o r :? pnn ~ 
Prin ted in L ',,s,A 
LIMITATIONS OF PROSTAGLANDIN 
ASSAYS 
WILLIAM E. M . LANDS. PH.D .. S. HAMMARSTROM. M.D ., AND C. W . PARKER, M .D. 
Department of Biological Ch emistr\' IWEMLl. The Univer>ity of M ichigan, Ann Arbor, Michigan , U. S, A.: 
Department of Chemi,<t", (SH I. Karolinska Institu te , St ockholm, Su'eden : S ec tion 0; Immunology ICWP), 
Departm ent of M edicine, Washington Uniuer.5ity, St. Louis, Missouri , U. S. A. 
The rapid evolution of quantitative met hods for 
detecting prostaglandins has im'oh-ed applied 
technology from a wide range of disciplines. As the 
many different techniques a re improved a nd ex-
tended to a variety of anal~·tical situations, a 
challenging array of choices is pro"ided to 
resea rchers. To asses the cur rent state of the 
technolog~' in a manner that might assist previ-
ously inexperienced workers in evaluating their 
poss ible alternatives in analyses, a modified 
" Delphi probe" or interact ive technology assess -
ment 11 ] was initiated, Est imates of time needed 
to prepare and analyze samples, of routine sen-
siti"ities, of t rain ing needed. and of relati"e cos t to 
conduct assays were obtained for nine diffe rent 
methods : silica gel: gas chromat ography- mass 
spectromet ry: gas chromat ography- electron cap-
ture: gas c hromatograph~' of radioactive de riva-
tives: high-speed liqu id c hromatogra ph~' : receptor 
or protein binding: radioimm une: enzymic: bioas-
say. 
Information was collected from 35 im'es tigators 
so that attention could be focuse d more quickl~' on 
those features that seem to be generally recognized 
similarly by all scientists as well as .those features 
for which there is a wide range of perceived \'alues 
or descriptions. The investigators (fro m 11 differ-
ent countries ) inc luded some inex perienced and 
many experienced indi"iduals, some of whom were 
widely recognized fo r their contributions to one or 
more assay procedure, 
Although many panicipants felt Ihat thei r 
"un informed" opinion was of no merit. examina -
t ion of their responses indica ted man~' case, of 
close agreement of opinion on procedural detai Is 
among experien ced and inexperienced workers . 
Perhaps the awareness that one ma~' be inexperi-
enced but st ill well informed will allow wider 
voluntary participa t ion in uch teaching- learning 
dialogues in tbe future. In a subsequent group 
dialogue, a disp lay of the range of opinions held b~' 
the experienced workers allowed all partici pants t o 
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Abbrevial ions: 
cAMP: cycl ic adenosine mo noph 05phate 
cGMP: cyclic guanosine monophosphate 
GC- MS: gas chroma togra ph y- rna" s peCI rometry 
RIA : radi oimmunoassay 
reevalua te (and the reby a lt er or reaffirm) thei l 
understa nding of t he Ii mits of the assay method 
In the gas chromawirra phi c- mass spectrophoto. 
metric method, inexperienced indiv iduals over· 
est.imated the amount of time needed for da ta 
processing, reflecting t heir unfamilia ri t:v with thE 
si mplicity of t he actual calcu lations needed for th i, 
assay . The instruments needed fo r the assa~' are 
com plex . The radioimmune assay can accommo-
date many samples at a time, but possib le inva lid 
results due to cross- react ing, interfering sub-
stances can require prior sample purificat ion. A 
wide range of time I from l to 300 min ) for sam ple 
prepara tion occu rs, reflecting a range of differen t 
sample sources wit h different needs for purification 
prior to assay. The sensit i ,·it~· of t his method i, 
greatest of all me thods re\'iewed , although a need 
for multiple determinations (for reli a ble accu racy) 
makes t he amount needed for a co mple te sample 
determinat ion se"eralfold greater t han t hat needed 
for one as ay measu rement. 
Radioimmunoassa~' s are c urre ntl~' the most 
pre,'alent mode of ana lysis of prostaglandins. The 
following technica l details are important in cycli c 
nucl eot ide rad ioim munoassays and probably a pply 
as well to p ros taglandin assays. 
The specificity of the antiserum. Selec ted a nti -
bod ies to cyclic nucleotides a re remarka hle in their 
ability to measure cycl ic adenosine monophos-
phate (cAMPI in t he presence of much hiirher 
co ncent ra tions of nonc.,'clic nuc leotides 121. often 
permitting measurements to be made on unfrac -
tionated tissue samples. It must be kept in mind . 
however , tha t antisera that a re ot herwise compara-
ble in terms of overall binding acti"i ty "ar~' by a, 
much as 3 logs in their sen ·it ivit ." a nd cross- reac-
ti ,·i t ~· wit. h noncyclic nucleot ides. Commercia l 
ant isera mayor may not meet the requi red stan· 
dards. 
Tissue processinli- Cycl ic nucleotide levels ,.-a r\', 
depending on how the ti ssue samples are har-
vested. stored, a nd processed priGI to rad ioim· 
munoassay. Enzymes wh ich form or h~·drol.vz f' 
cycl ic nucleotides mus t he inactivated although 
the inact i"ation process itself may lead to spuriou, 
results . For example. cAMP or cyclic guanosine 
monophosphate (cGMP) can be generated by boil · 
ing the homologous nucleotide triphosphate in t h. 
presence of appropriate divalent cations . 
Unexpected cross-reactivities and nonspecifi, 
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immunoassay inhibition. Theophylline and nor-
epinephrine cause inhibition in the cGMP im-
munoassay, for reasons that are not enti rely clear. 
Changes in ionic strength and pH also can give 
spurious results. Other nonspecific inhibitory 
effects are sometimes observed in tissue extracts 
[3]. 
A number of quality controls a re recommended 
[4 1 to help in validating cyclic nucleotide (or other ) 
immunoassays: 
1. Parti cularly in the early stages of assay devel-
opment. it is helpful to demonstrate tha t 
im munoassay values in tissue correspond 
with those obtained by other methods. 
2. Added quantities of cyclic nucleotide shou ld 
produce the expected increment in the 
immunoassay. 
3. Immunoreac t ive antigen in the tissue sample 
should co-chromatograph .... 'ith trace amounts 
of radiolabeled antigen, preferably in more 
than one chromatographi c system. 
4. U' an enzyme capab le of destroyin1! a ntigen in 
the tissue sample is available. it should re-
duce the immunoreact ivity of the sample to 
low levels. 
5. Quantities of cross- reacting antigens known 
to be present in tissue samples shou ld be 
shown not to influence the assav or be re-
moved by a . uitable fractionation' procedure. 
6. Every tissue sample must be handled as 
comparably as possible to avoid spurious 
effects of pH or ionic strength in the assay. 
All stimulatory agents must be evaluated in 
the absence of tissue for nonspecific effect 
in the assay. A good example of the problems 
that can ari e a re the changes in marker bind-
ing that occur in c~'clic nucleotide immuno-
85says when Mg" or Ca ,. concennat ions are 
alte red. 
7. Since antibodies to cAMP and cG MP are di-
rected toward 2'-0 substituted deri\·ati\·es. 
t reatment of tissue samples with acetic or 
succinic anh~'d ride may increase the sensi t iv-
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ity and speciJicity of the immunoassay. How-
ever, care must be taken to ensure that the 
substitution reaction proceeds quantitatively. 
Examples of the results reviewed by tbe con-
ferees are given in Figure 1. The corners of the trio 
angles indicate the lower, middle. and upper quar-
tiles of response for the whole group of participants 
(open triangles) or for the subset who have had ex-
perience with the method (hatched triangles). The 
numbers on the abscissa indicate the upper and 
lower quartile values , an d the distance between 
them is divided into 10 equal portions. For 
example, the number of prostaglandin assays per 
day with the silica gel method was regarded as ;, 
per day by the lower quartile. about 15 per day b~' 
the median respondent. and 20 per day by the 
upper quartile. In this ca e, the LOtal group per· 
ceived the va lues in the same way tha t those with 
experience did. Apparent ly. the current modes of 
communication have allowed inexperienced scien· 
tists to acquire some of the information obtained by 
the experienced workers . 
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FIG. 2. The inexperienced participants tended to un-
derestimate t he number of assays per day that could be 
done bv the bioa say method and overest imate the num-
ber of pmoles needed per assay. The part icipants seemed 
in full agreement on the approximate nu mber uf bio-
assavs done annuallv in the United States. but t ho e 
with'out experience did not em'ision the larger extent of 
bioassays done in Europe and Africa that experienced 
workers saw. 
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FIG. 1. Upper row: The number of pmoles needed per assay was great fo r lhe ilica gel method. but simila r for the 
other three methods. Second rOu': T he number of assa ys lhat could be run in one day waS similar for all four methods. 
with RIA somewhat grealer. Third row: The numbe~ of minutes needed for data processing was much less fo r the 
experienced partici pants (GC-MS ). Bottom roU': Equipment costs were greater for GC-MS and bioassay methods, but 
refocused estimat.es are needed to narrow t.he range given. 
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Some situations in which the knowledge of the 
experienced workers seemed inadequately shared 
with the total group ar e noted in Figure 2. The 
agTeement on the estimat.ed bioassays run annually 
in the United States may indicate shared informa-
t ion among those from the Unit ed States (60% 
participants) that did not include information 
about the ext.ent of work in other countries. (Note 
the lack of common awareness between the tot.al 
gToup and experienced subset regarding bioassays 
in Europe and Africa.) 
To illustrate the teaching- learning potential of 
such int.eractive assessment.s. est imates by the 
participants after the l-hr review were info rmally 
compared to their ini tial estimates. and those in-
Vol. 67, No.5 , Pa rt 2 of 2 part. 
dividuals showing the great.est amount of' " learn-
ing" were appropriately recognized. 
The authors t hank Joyce Gilson for developing the 
computer pro!(rams used in processi ng the data. 
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